LOREN CRAGLE: Open Payments
NPI 1538406491 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,538 in 166 payments from 27 companies in 2025. Trend: 2023 $2,768 · 2024 $6,416 · 2025 $21,538
Speaker / faculty: $15,450Food & beverage: $3,788Travel & lodging: $2,151Education: $149
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 36 | $13,007 |
| TG Therapeutics, Inc. | 20 | $6,044 |
| Amgen Inc. | 9 | $433 |
| Teva Pharmaceuticals USA, Inc. | 34 | $356 |
| ABBVIE INC. | 13 | $226 |
| Eisai Inc. | 2 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $143 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| Biogen, Inc. | 4 | $99 |
| Neurocrine BioSciences, Inc. | 4 | $95 |
Products named: Mavenclad, BRIUMVI, UPLIZNA, AUSTEDO XR, Leqembi, HYQVIA, UBRELVY, KESIMPTA.
Industry payments across SC — which companies pay providers there.
